רמיקד ישראל - עברית - Ministry of Health

רמיקד

j-c health care ltd - infliximab - אבקה להכנת תרכיז לאינפוזיה - infliximab 100.0 mg/vial - infliximab - infliximab - - adult :crohn's disease: treatment of severe active crohn's disease in patients who have not responded despite of a full and adequate course of therapy with a corticosteroid and/or an immunosuppressant. treatment of fistulising crohn's disease in patients who have not responded despite of a full and adequate course of therapy with conventional treatment. -paediatric crohn's disease: remicade is indicated for: treatment of severe active crohn's disease in paediatric patients aged 6 to 17 years who have not responded to conventional therapy including a corticosteroid an immunomodulator and primary nutrition therapy or who are intolerant to or have contraindications for such therapies. remicade has been studied only in combination with conventional immunosuppressive therapy -ankylosing spondylitis: remicade is indicated for: treatment of ankylosing spondylitis in patients who have severe axial symptoms elevated serological markers of inflammatory activity and who have responded inadequately to conventional ther

נאורונטין 300 מג ישראל - עברית - Ministry of Health

נאורונטין 300 מג

pfizer pfe pharmaceuticals israel ltd - gabapentin - קפסולות - gabapentin 300 mg - gabapentin - gabapentin - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy.

נאורונטין 300 מג ישראל - עברית - Ministry of Health

נאורונטין 300 מג

pfizer pfe pharmaceuticals israel ltd - gabapentin - קפסולות - gabapentin 300 mg - gabapentin - gabapentin - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy.

נאורונטין 400 מג ישראל - עברית - Ministry of Health

נאורונטין 400 מג

pfizer pfe pharmaceuticals israel ltd - gabapentin - קפסולות - gabapentin 400 mg - gabapentin - gabapentin - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy.

נאורונטין 400 מג ישראל - עברית - Ministry of Health

נאורונטין 400 מג

pfizer pfe pharmaceuticals israel ltd - gabapentin - קפסולות - gabapentin 400 mg - gabapentin - gabapentin - as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults with epilepsy.

יומירה ישראל - עברית - Ministry of Health

יומירה

abbvie biopharmaceuticals ltd, israel - adalimumab - תמיסה להזרקה - adalimumab 100 mg / 1 ml - adalimumab

רמסימה 120 מגמל תת-עורי ישראל - עברית - Ministry of Health

רמסימה 120 מגמל תת-עורי

padagis israel agencies ltd, israel - infliximab - תמיסה להזרקה - infliximab 120 mg/ml - infliximab

פלומיסט קואדריוואלנט ישראל - עברית - Ministry of Health

פלומיסט קואדריוואלנט

astrazeneca (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - ספריי לאף - b/phuket/3073/2013 (b/yamagata lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/darwin/9/2021 (h3n2)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 7 ±0.5 log10 ffu^a / 0.2 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - flumist quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses ad type b viruses contained in the vaccine. flumist quadrivalent is approved for use in persons 2 through 49 years of age.

זוסטאווקס (ZOSTER VACCINE LIVE) ישראל - עברית - Ministry of Health

זוסטאווקס (zoster vaccine live)

merck sharp & dohme (israel - 1996) company ltd, israel - live attenuated oka/merck strain of varicella-zoster virus - אבקה וממס להכנת תרחיף להזרקה - live attenuated oka/merck strain of varicella-zoster virus 19400 pfu / 0.65 ml - zoster, live attenuated - zoster, live attenuated - zostavax is a live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in individuals 50 years of age and older.